The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Gleevec/Glivec was produced by Novartis.
The drug will be administered intravenously for seven days. Hailed as a miracle anticancer drug when it was launched in 2008, Novartis’ Gleevec (imatinib), a small molecule tyrosine kinase inhibitor, may
Chemotherapy and radiotherapy is notoriously ineffective in GIST. At the moment the standard approach to treating patients who aren’t eligible for surgery is older kinase inhibitor drugs like Novartis’ Glivec
On the downside, revenues from post-patent expiry cancer drug Glivec continued to decline (down 20% to $1.56bn).
We’re a Healthcare Communications Agency specialising in Multi-channel Marketing to make you Digitally Fitter, Stronger & Faster....